|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/397 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61K 31/502 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3129021 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15717381.6 |
| Date of filing the European patent application | 2015-04-07 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation | 2020-12-10 |
| (86) | Number | PCT/US2015/024676 |
| Date | 2015-04-07 |
| (87) | Number | WO 2015/157257 |
| Date | 2015-10-15 |
| (30) | Number | Date | Country code |
| 201461976815 P | 2014-04-08 | US |
| (72) |
SCHERLE, Peggy A., US
LIU, Xuesong, US
|
| (73) |
Incyte Holdings Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | B ląstelių piktybiškumo gydymas JAK ir PI3K inhibitorių deriniu |
| TREATMENT OF B-CELL MALIGNANCIES BY A COMBINATION JAK AND PI3K INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2026-03-18 | 12 | 289.00 EUR |
| 2027-04-07 |